SMLL:ARCA-Direxiion Daily Small Cap Bull 2X Shares (USD)

ETF | Trading--Leveraged Equity | NYSE Arca

Last Closing

USD 20.1965

Change

+0.43 (+2.17)%

Market Cap

USD 0.01B

Volume

979.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

The investment seeks daily investment results, before fees and expenses, of 200% of the performance of the Russell 2000? Index. The fund, under normal circumstances, creates long positions by investing at least 80% of its assets in the securities that comprise the Russell 2000? Index and/or financial instruments that provide leveraged and unleveraged exposure to the index. The index measures the performance of the small-cap segment of the U.S. equity universe and is comprised of the smallest 2,000 companies in the Russell 3000? Index, representing approximately 8% of the total market capitalization of that index. The fund is non-diversified.

Inception Date: 29/07/2014

Primary Benchmark: Russell 2000 TR USD

Primary Index: S&P 500 TR USD

Gross Expense Ratio: 1.52%

Management Expense Ratio: 0.28 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings

N/A

Symbol Company Name Allocation
TARS Tarsus Pharmaceuticals Inc 3.56 %
Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-02 )

Largest Industry Peers for Trading--Leveraged Equity

Symbol Name Mer Price(Change) Market Cap
SOXL Direxion Daily Semiconductor B.. 1.10 %

-0.24 (-1.81%)

USD 8.14B
QLD ProShares Ultra QQQ 0.95 %

-1.10 (-1.18%)

USD 5.50B
SSO ProShares Ultra S&P500 0.90 %

-0.90 (-1.09%)

USD 4.33B
FNGU MicroSectors FANG+ Index 3X Le.. 0.00 %

N/A

USD 4.29B
UPRO ProShares UltraPro S&P500 0.92 %

-1.18 (-1.64%)

USD 2.91B
TECL Direxion Daily Technology Bull.. 1.17 %

-0.96 (-1.59%)

USD 1.95B
YINN Direxion Daily FTSE China Bull.. 1.02 %

-0.03 (-0.09%)

USD 1.19B
USD ProShares Ultra Semiconductors 0.95 %

-0.52 (-1.24%)

USD 0.61B
UDOW ProShares UltraPro Dow30 0.95 %

-0.45 (-0.57%)

USD 0.56B
LABU Direxion Daily S&P Biotech Bul.. 1.14 %

-1.76 (-2.86%)

USD 0.53B

ETFs Containing SMLL

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Leveraged Equity) Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -7.18% 51% F 28% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -7.18% 51% F 27% F
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain -23.43% 12% F 14% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -23.43% 12% F 10% F
Average Annual (5 Year Horizon)  
Capital Gain 15.98% 47% F 80% B-
Dividend Return 16.00% 46% F 77% C+
Total Return 0.02% 2% F 1% F
Risk Return Profile  
Volatility (Standard Deviation) 102.55% 24% F 7% C-
Risk Adjusted Return 15.60% 32% F 34% F
Market Capitalization 0.01B N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.